Xilio Therapeutics reported total assets of $154.25M and total liabilities of $81.99M for the quarter ended Jun 2026, up 15.3% year over year. This balance sheet covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 99.77M | 198.05M | 176.96M | 159.41M | 139.14M | 120.39M | 93.27M | 75.38M | 59.77M | 44.70M | 33.98M | 74.95M | 61.26M | 55.29M | 89.07M | 121.55M | 103.76M | 137.53M | 150.33M | 136.04M | ||||
| Cash & Current Investments | 99.77M | 198.05M | 176.96M | 159.41M | 139.14M | 120.39M | 93.27M | 75.38M | 59.77M | 44.70M | 33.98M | 74.95M | 61.26M | 55.29M | 89.07M | 121.55M | 103.76M | 137.53M | 150.33M | 136.04M | ||||
| Receivables - NetNet Receivables | 30.00M | |||||||||||||||||||||||
| Receivables | 30.00M | |||||||||||||||||||||||
| Prepaid Assets | 3.40M | 4.46M | 4.13M | 3.60M | 3.17M | 4.11M | 3.71M | 3.04M | 4.71M | 3.42M | 5.21M | 3.06M | 2.05M | 4.94M | 4.13M | 2.17M | 2.83M | 2.50M | 3.87M | 3.43M | ||||
| Current Assets | 105.57M | 202.52M | 181.09M | 163.01M | 142.31M | 124.50M | 96.98M | 78.42M | 64.48M | 48.13M | 69.19M | 78.01M | 63.31M | 60.23M | 93.20M | 123.72M | 124.09M | 145.03M | 154.21M | 145.47M | ||||
| Non-Current Assets | ||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 7.11M | 7.62M | 7.47M | 7.44M | 7.55M | 7.25M | 7.25M | 6.80M | 6.37M | 5.94M | 5.54M | 5.14M | 4.84M | 4.47M | 4.29M | 4.02M | 3.68M | 3.89M | 3.68M | 3.36M | ||||
| Other Non-Current Assets | 1.55M | 1.55M | 1.55M | 1.55M | 1.56M | 1.56M | 1.57M | 1.57M | 1.58M | 1.59M | 2.76M | 1.77M | 1.77M | 1.78M | 1.79M | 1.79M | 1.80M | 1.81M | 1.81M | 1.82M | ||||
| Non-Current Assets | 15.15M | 15.54M | 15.27M | 15.12M | 15.10M | 14.67M | 14.53M | 13.93M | 13.36M | 12.80M | 13.42M | 11.87M | 11.35M | 10.84M | 10.52M | 10.10M | 9.61M | 9.66M | 9.28M | 8.79M | ||||
| Assets | 120.72M | 218.06M | 196.35M | 178.13M | 157.41M | 139.16M | 111.50M | 92.36M | 77.84M | 60.93M | 82.61M | 89.87M | 74.66M | 71.08M | 103.72M | 133.81M | 133.69M | 154.69M | 163.49M | 154.25M | ||||
| Liabilities | ||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||
| Accounts Payables | 3.82M | 3.14M | 2.32M | 1.41M | 1.81M | 3.12M | 2.01M | 0.94M | 1.49M | 1.05M | 0.75M | 1.26M | 0.97M | 2.57M | 2.27M | 4.10M | 2.30M | 3.17M | 1.06M | 2.31M | ||||
| Notes Payables | 1.67M | 3.33M | 5.00M | 6.67M | 6.67M | 7.14M | 4.96M | 3.31M | ||||||||||||||||
| Payables | 3.82M | 3.14M | 3.99M | 4.74M | 6.81M | 9.79M | 8.68M | 8.09M | 6.44M | 4.37M | 0.75M | 1.26M | 0.97M | 2.57M | 2.27M | 4.10M | 2.30M | 3.17M | 1.06M | 2.31M | ||||
| Accumulated Expenses | 8.19M | 8.75M | 7.32M | 12.09M | 9.06M | 10.33M | 6.48M | 7.14M | 9.40M | 10.50M | 8.00M | 9.74M | 9.79M | 9.98M | 3.88M | 5.62M | 8.95M | 11.74M | 8.97M | 7.85M | ||||
| Other Accumulated Expenses | 0.29M | 0.32M | 0.19M | 0.30M | 0.26M | 0.20M | 0.27M | 0.23M | 0.17M | 0.10M | 0.11M | 0.13M | 0.14M | 0.13M | 0.17M | 0.20M | 0.09M | 0.08M | 0.20M | 0.09M | ||||
| Current Leases | 0.77M | 0.80M | 0.83M | 0.86M | 0.89M | 0.92M | 0.95M | 0.98M | 1.01M | 1.05M | 1.08M | 1.12M | 1.15M | 1.19M | 1.23M | 1.26M | 1.30M | 1.34M | 1.38M | 1.43M | ||||
| Current Deferred Revenue | 21.73M | 26.52M | 26.11M | 32.78M | 78.99M | 70.91M | 69.34M | 60.66M | 48.01M | 35.32M | ||||||||||||||
| Total Current Liabilities | 12.87M | 12.78M | 12.22M | 17.77M | 16.84M | 21.12M | 16.19M | 16.29M | 16.93M | 15.96M | 31.58M | 38.64M | 38.02M | 27.26M | 47.64M | 53.26M | 56.40M | 56.27M | 42.96M | 34.20M | ||||
| Non-Current Liabilities | ||||||||||||||||||||||||
| Non-Current Debt | 9.58M | 9.63M | 8.01M | 6.39M | 4.78M | 3.17M | 1.55M | |||||||||||||||||
| Non-Current Deffered Revenue | 17.40M | 10.25M | 8.40M | 19.26M | 38.74M | 28.63M | 25.50M | 20.64M | 16.47M | 12.71M | ||||||||||||||
| Preferred Stock Liabilities | 222.89M | |||||||||||||||||||||||
| Operating Leases | 10.32M | 10.11M | 9.89M | 9.66M | 9.43M | 9.19M | 8.95M | 8.68M | 8.41M | 8.14M | 7.86M | 7.57M | 7.26M | 6.95M | 6.64M | 6.30M | 5.96M | 5.61M | 5.25M | 4.88M | ||||
| Other Non-Current Liabilities | 1.52M | 0.12M | 0.10M | 0.08M | 0.06M | 0.04M | 0.03M | 0.01M | 38.55M | 53.93M | 29.56M | 26.26M | 30.20M | |||||||||||
| Total Non-Current Liabilities | 32.77M | 32.51M | 30.13M | 33.83M | 31.05M | 33.47M | 26.69M | 24.98M | 88.19M | 87.86M | 89.85M | 64.68M | 51.79M | |||||||||||
| Total Liabilities | 34.29M | 32.63M | 30.23M | 33.91M | 31.12M | 33.52M | 26.71M | 24.98M | 25.34M | 24.10M | 56.84M | 56.46M | 53.68M | 53.48M | 93.02M | 126.74M | 141.79M | 119.41M | 90.94M | 81.99M | ||||
| Shareholder's Equity | ||||||||||||||||||||||||
| Total Debt | 9.58M | 9.63M | 9.68M | 9.73M | 9.78M | 9.83M | 8.21M | 7.14M | 4.96M | 3.31M | ||||||||||||||
| Common Equity | -136.46M | 185.43M | 166.12M | 144.22M | 126.30M | 105.65M | 84.79M | 67.38M | 52.50M | 36.83M | 25.77M | 33.42M | 20.97M | 17.60M | 10.70M | 7.07M | -8.10M | 35.27M | 72.55M | 72.26M | ||||
| Liabilities and Shareholders Equity | 120.72M | 218.06M | 196.35M | 178.13M | 157.41M | 139.16M | 111.50M | 92.36M | 77.84M | 60.93M | 82.61M | 89.87M | 74.66M | 71.08M | 103.72M | 133.81M | 133.69M | 154.69M | 163.49M | 154.25M | ||||
| Retained Earnings | -141.19M | 346.31M | 348.36M | 351.07M | 352.94M | 354.75M | 356.54M | 358.48M | 360.35M | 362.34M | 368.48M | 390.05M | 391.63M | 401.35M | 407.71M | 419.93M | -429.15M | 454.06M | 500.86M | 506.95M | ||||
| Treasury Shares | 174.78M |